Dorsey & Whitney Trust’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,309
Closed -$682K 730
2025
Q4
$682K Sell
8,309
-243
-3% -$18.9K 0.04% 364
2025
Q3
$642K Sell
8,552
-73
-0.8% -$5.45K 0.03% 366
2025
Q2
$639K Sell
8,625
-222
-3% -$15.5K 0.03% 371
2025
Q1
$714K Buy
8,847
+881
+11% +$75.7K 0.04% 328
2024
Q4
$623K Buy
7,966
+107
+1% +$9.1K 0.03% 352
2024
Q3
$738K Buy
7,859
+83
+1% +$6.97K 0.04% 323
2024
Q2
$606K Buy
7,776
+1,054
+16% +$86K 0.04% 311
2024
Q1
$611K Buy
6,722
+837
+14% +$69.6K 0.04% 314
2023
Q4
$455K Buy
5,885
+1,038
+21% +$72.7K 0.03% 362
2023
Q3
$330K Buy
+4,847
New +$353K 0.03% 405

Other funds holding GEHC

Dorsey & Whitney Trust's GEHC Position: Q1 2026 in Review

Dorsey & Whitney Trust sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 8,309 shares — an estimated $682K sold.

Dorsey & Whitney Trust first reported a position in GEHC in Q3 2023 and held it in 10 quarters. The position peaked at $738K in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Dorsey & Whitney Trust reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 8,309 GE HealthCare shares in Q1 2026, an estimated $682K.
  • Dorsey & Whitney Trust first reported a position in GE HealthCare in Q3 2023 and held it in 10 quarters.
  • Dorsey & Whitney Trust's GE HealthCare position peaked at $738K in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.